An interventional study of Ventilatory manipulation in Spinal Cord Injuries (SCI), sponsored by University of Calgary. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by University of Calgary · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 204 studies in Spinal Cord Injuries with a site in Canada — 67 open to participants now, 74 under way, 4 of them phase 3. Spinal Cord Injuries · Canada.
Among the 204 studies in Spinal Cord Injuries with a site in Canada, this one is the 113th largest by planned enrollment of the 179 interventional ones that give a count, is one of 7 that started in 2027, is one of 127 with no phase, reaches primary completion later than 65 of the 73 other live ones, and was the 204th registered.
2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.
Browse Spinal Cord Injuries studies →67 of the 204 studies in Spinal Cord Injuries with a site in Canada are open now. Recruiting first, the newest first:
University of Alberta · Sites in Canada
Ages 18+
Dr. B. Catharine. Craven · Sites in Canada
Ages 18–75
University of British Columbia · Sites in Canada
Ages 19+
University of Alberta · Sites in Canada
Ages 18+
University of British Columbia · Sites in Canada
Ages 19+
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
204 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 27 · Phase 3 18 · Phase 4 8
First in 1999; this study’s year is marked. 7 started in 2027.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 16 is below the median of 24 across 1,639 interventional studies indexed under Spinal Cord Injuries.
Median enrollment 24 across the 179 interventional studies, 42 across the 25 observational. Of the 109 that completed or were terminated, 13 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
17 of 204 have an industry lead sponsor. The 10 most frequent:
University of Calgary is the lead sponsor of 704 studies on the registry; 197 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 2 (20%) have results posted.
University of Calgary has 7 studies filed under Spinal Cord Injuries — fewer than ten, so there is no comparison to draw.
20 of the studies in Spinal Cord Injuries with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07147296ONWARD Medical, Inc.ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury | 2026-11 |
| NCT06828653Holland Bloorview Kids Rehabilitation HospitalComparing Digitally and Traditionally Made Ankle Foot Orthoses | 2026-12 |
| NCT06691165Glen FosterImproving 24-hour Blood Pressure Stability in Spinal Cord Injury With Low Oxygen Therapy | 2026-12 |
| NCT06807528London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sIntermittent Fasting for Inflammation and Depression in Spinal Cord Injury | 2026-12-30 |
| NCT05103436University of AlbertaElectrical Stimulation for Spasticity in Spinal Cord Injury | 2026-12-31 |
Add all 20 to your calendar (.ics) → With an account.
Among the 204 studies in Spinal Cord Injuries with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to measure spinal cord blood flow in participants with acute cervical or high-thoracic spinal cord injury. During planned spinal cord decompression surgery after acute spinal cord injury, participants will have a blood flow sensor placed around the area of injury. The participant's breathing rate and depth, which is controlled via a ventilator as part of standard surgical care, will be manipulated to test whether progressively increasing carbon dioxide levels increases spinal cord blood flow. This will provide the first safety data of the effects of altering carbon dioxide intraoperatively for spinal cord injury.
This single-centre, prospective, randomised feasibility trial will enroll 16 participants with acute traumatic spinal cord injury (SCI) undergoing surgical decompression at the Foothills Medical Centre.
After SCI, impaired spinal cord perfusion and oxygenation drive secondary injury and worsen recovery. Current care raises systemic blood pressure with vasopressors, which has limited evidence of improving spinal cord oxygenation or neurological outcome. Carbon dioxide (CO₂) is a central nervous system vasodilator, and the investigators have shown preclinical pilot studies that increasing CO₂ increases spinal cord blood flow and oxygenation. This trial is the first test in humans of whether raising arterial CO₂ can increase spinal cord tissue oxygenation during acute SCI.
The investigators will recruit participants with acute SCI undergoing spinal decompression surgery. The investigators will randomise participants to one of two arms. In the intervention arm (n=10), the attending anaesthesiologist will titrate end-tidal CO₂ to 35, 45, 55, and 65 mmHg by adjusting ventilator settings (permissive hypercapnia; no exogenous CO₂ is given), holding each level for approximately five minutes. In the comparison arm (n=6), the investigators will take the same measurements under standard care without manipulating CO₂, to provide reference values. All participants receive full standard surgical and anaesthetic care; the study adds only the intraoperative measurement and, in the intervention arm, the ventilatory manipulation.
Following operative decompression and laminectomy, the investigators will measure spinal cord tissue oxygenation using the Integra LICOX monitoring system, which records tissue partial pressure of oxygen and temperature from a probe placed on the spinal cord tissue. The investigators will record systemic hemodynamics, arterial blood gases, and ventilatory parameters continuously. The investigators will track peri- and post-operative adverse events and clinical endpoints from the medical record, and the investigators will interview participating surgeons, anaesthesiologists, and patients about feasibility and safety.
The specific aims of this trial are to:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anesthesiologist will intentionally adjust the patient's breathing rate and depth for a brief period to titrate end-tidal CO2 to predetermined levels, which will then be held for 5 min intervals. End-tidal CO₂ will be titrated to 35, 45, 55, and 65 mmHg.
Other: Ventilatory manipulation
Participants will receive the same standard surgical care the ventilatory manipulation arm, but without intentional adjustment of ventilation to achieve predetermined CO2 levels. Participants in this arm will also have spinal cord oxygenation measured.
Participants will be receiving mechanical ventilation as part of their standard care. The clinical operating team, specifically the attending anesthesiologist, will adjust their level of ventilation (breathing rate, depth) to achieve predetermined levels of end-tidal CO2. Spinal cord oxygenation will be measured in all participants before, during, and after ventilatory manipulation.
Spinal cord tissue oxygenation during intraoperative monitoring
Spinal cord tissue oxygenation, measured as tissue partial pressure of oxygen (PtO₂) using the Integra LICOX monitoring system, recorded continuously during the intraoperative monitoring period in both arms. In the intervention arm, PtO₂ is assessed across stepwise end-tidal CO₂ levels (35, 45, 55, 65 mmHg, held approximately five minutes each) to characterise the dose-response relationship between end-tidal CO₂ and spinal cord tissue oxygenation. In the comparison arm, PtO₂ is recorded under standard care without CO₂ manipulation to provide reference values.
Time frame: Intraoperative, during the ventilatory titration protocol (approximately 20 to 30 minutes), from pre-titration baseline through each end-tidal CO₂ level (35, 45, 55, 65 mmHg).
Incidence of peri- and post-operative adverse events
Incidence, type, and severity of peri- and post-operative adverse events (for example, arrhythmias, acid-base disturbance, hemodynamic instability), abstracted from the medical record and coded in alignment with the NINDS Common Data Elements. Events are summarised by arm and by relationship to the study procedures, to assess the safety of intraoperative end-tidal CO₂ titration.
Time frame: From surgery through acute hospital discharge (up to approximately 30 days).
Systemic blood pressure during intraoperative monitoring
Systemic blood pressure (mean arterial pressure) recorded continuously during the intraoperative monitoring period in both arms. In the intervention arm, values are assessed across stepwise end-tidal CO₂ levels (35, 45, 55, 65 mmHg) to characterise the hemodynamic response to ventilatory CO₂ manipulation. In the comparison arm, values are recorded under standard care without CO₂ manipulation to provide reference values.
Time frame: Intraoperative, during the ventilatory titration protocol (approximately 20 to 30 minutes).
Arterial carbon dioxide during intraoperative monitoring
Arterial blood gas values (PaCO₂, PaO₂, pH) measured from the arterial line and recorded continuously during the intraoperative monitoring period in both arms. In the intervention arm, values are assessed across stepwise end-tidal CO₂ levels (35, 45, 55, 65 mmHg) to confirm the achieved degree of hypercapnia and to monitor acid-base status (protocol conducted only while pH ≥ 7.3). In the comparison arm, values are recorded under standard care without CO₂ manipulation.
Time frame: Intraoperative, during the monitoring period (approximately 20 to 30 minutes).
Heart rate during intraoperative monitoring
Heart rate (beats per minute) recorded continuously during the intraoperative monitoring period in both arms. In the intervention arm, values are assessed across stepwise end-tidal CO₂ levels (35, 45, 55, 65 mmHg) to characterise the hemodynamic response to ventilatory CO₂ manipulation. In the comparison arm, values are recorded under standard care without CO₂ manipulation to provide reference values.
Time frame: Intraoperative, during the ventilatory titration protocol (approximately 20 to 30 minutes).
Arterial oxygen during intraoperative monitoring
Arterial oxygen values (PaO₂) measured from the arterial line and recorded continuously during the intraoperative monitoring period in both arms. In the intervention arm, values are assessed across stepwise end-tidal CO₂ levels (35, 45, 55, 65 mmHg) to confirm arterial oxygenation is maintained. In the comparison arm, values are recorded under standard care without CO₂ manipulation.
Time frame: Intraoperative, during the ventilatory titration protocol (approximately 20 to 30 minutes).
Acid-base balance during intraoperative monitoring
Acid-base balance (pH) measured from the arterial line and recorded continuously during the intraoperative monitoring period in both arms. In the intervention arm, values are assessed across stepwise end-tidal CO₂ levels (35, 45, 55, 65 mmHg) to confirm acid-base balance is maintained. In the comparison arm, values are recorded under standard care without CO₂ manipulation.
Time frame: Intraoperative, during the ventilatory titration protocol (approximately 20 to 30 minutes).
Plan to share: Yes — De-identified individual participant data underlying the primary outcome (spinal cord tissue oxygenation, PtO₂) and secondary outcomes (systemic hemodynamics, arterial blood gases, adverse events) will be shared. Only de-identified, processed data will be shared; raw data and qualitative interview transcripts will not be shared. Sharing is subject to approval by the University of Calgary Conjoint Health Research Ethics Board and consistent with participant consent.
Supporting information: Study protocol, Statistical analysis plan, Clinical study report, Analytic code
Time frame: Data and supporting information will be made available after publication of the primary trial results, with no planned end date (data will remain available in the repository indefinitely, subject to repository terms).
Access criteria: De-identified data and supporting documents will be deposited in the Open Data Commons for Spinal Cord Injury (ODC-SCI) repository and shared following FAIR principles. Access will be available to qualified researchers through the repository's standard access process, following University of Calgary ethics and privacy requirements. Custom analysis code will be made available via GitHub. Requests may also be directed to the Principal Investigator (Dr. Aaron Phillips).
Data sharing details ↗ · odc-sci.org
Start is estimated for Jan 2027; primary completion for Jan 2030, 36 months later.
Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 36 months is close to that.
Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.